According to the latest report by IMARC Group, titled “Diabetic Retinopathy Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026”, the global diabetic retinopathy market reached a value of US$ 7.64 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.6% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/diabetic-retinopathy-market/requestsample
Diabetic retinopathy (DR) stands for the damage caused to the blood vessels in the retina by diabetes mellitus. It is caused by fluctuations in the blood glucose levels, leading to abnormal growth in the light-sensitive tissues of the eye. The symptoms of DR include blurred or fluctuating vision, the appearance of dark spots or floating strings in the vision field, impaired color vision, loss of vision, etc. It can be diagnosed with tests like fluorescein angiography, optical coherence tomography, etc., and is treated with intraocular steroid injection, laser treatment, vitrectomy, etc.
The rising geriatric population and increasing numbers of diabetic individuals are primarily driving the growth of the DR market. Moreover, the increasing incidences of blindness caused by DR are also augmenting the market growth. Additionally, the growing consumer awareness towards early detection and alternative treatments for DR is leading to the widespread adoption of technologically advanced procedures and equipment. The introduction of ophthalmic diagnostic and surgical instruments helps in facilitating early diagnosis and efficient treatment with high precision and minimal discomfort for the patient. Besides this, the launch of favorable government policies for the upgradation of healthcare services is expected to further strengthen the global market in the coming years.
Diabetic Retinopathy Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global diabetic retinopathy market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Alimera Sciences
- Allergan Plc
- Ampio Pharmaceuticals
- Bayer Healthcare
- BCN Peptides
- Genentech
- Kowa Group
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Sirnaomics Inc.
Key Market Segmentation:
The report has segmented the global diabetic retinopathy market on the basis of type, treatment type, end user and country.
Breakup by Type:
- Proliferative Diabetic Retinopathy
- Non-proliferative Retinopathy
Breakup by Treatment Type:
- Anti VEGF Drugs
- Steroid Implants
- Laser Surgeries
- Vitrectomy
Breakup by End-User:
- Hospitals and Pharmacies
- Eye Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/diabetic-retinopathy-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
- UAE Health Insurance Market By IMARC Group
- Saudi Arabia Health Insurance Market By IMARC Group
- Hospital-Acquired Disease Testing Market By IMARC Group
- Stem Cell Banking Market By IMARC Group
- Hearing Aid Market By IMARC Group
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Comments
Post a Comment